Arcutis Biotherapeutics (ARQT) said Thursday that Latha Vairavan, currently vice president and controller, will assume the role of chief financial officer.
Vairavan will succeed David Topper, who is retiring from the firm, Arcutis said. Topper will continue as CFO until the company's Q1 filing and provide transition support through May 15.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.